As representatives of 50 leading academic medical centers focusing on clinical research and many of academic medicine’s scientific leaders, the Clinical Research Forum and Association of American Physicians disagree with the JCI’s recent editorials on the NIH Roadmap, Elias Zerhouni’s leadership, and the future directions of biomedical research.
William Crowley Jr., John Courtney, Larry Jameson, Herbert Pardes, Jay Moskowitz, Eugene Orringer , Arthur Rubenstein, Alastair Wood, Richard Rettig, Dennis Ausiello, David Brenner, Francis Collins, Jack Elias, Warner Greene, Ralph Horowitz, Larry Jameson, Elliott Kieff, Craig Thompson, Judith L. Swain
We, the directors of the 27 NIH institutes and centers, wanted to respond to the points made by Andrew Marks in his recent editorial. While we appreciate that the scientific community has concerns, the current initiatives and directions of the NIH have been developed through planning processes that reflect openness and continued constituency input, all aimed at assessing scientific opportunities and addressing public health needs.
Duane F. Alexander, Barbara M. Alving, James F. Battey Jr., Jeremy M. Berg, Francis S. Collins, Anthony S. Fauci, John I. Gallin, Patricia A. Grady, Richard J. Hodes, Sharon H. Hrynkow, Thomas R. Insel, Jack F. Jones, Stephen I. Katz, Story C. Landis, Ting-Kai Li, Donald A. Lindberg, Elizabeth G. Nabel, John E. Niederhuber, Roderic I. Pettigrew, Griffin P. Rodgers, John Ruffin, Antonio Scarpa, David A. Schwartz, Paul A. Sieving, Stephen E. Straus, Lawrence A. Tabak, Nora D. Volkow
Andrew Marks’ recent editorial eloquently reiterated a concern that many of us have voiced before, that the current policies and practices of the NIH are not serving the public well.
Gerald Weissmann
For a number of reasons, the NIH and the biomedical research community are facing a period of fiscal constraint after pronounced growth. In these difficult times, it is important that we all speak from the facts and work together to do a better job of explaining the importance of the nation’s investment in biomedical research.
Norka Ruiz Bravo
Qing Wang, Shaoqi Rao, Eric J. Topol
Li Weng, Jonathan Cohen, Ruth McPherson, Len A. Pennacchio
No posts were found with this tag.